Literature DB >> 11574762

Targeting protein kinases for tumor therapy.

C Sachsenmaier1.   

Abstract

Phosphorylation is the most common biochemical modification of cellular molecules, regulating fundamental cellular processes like growth, differentiation, proliferation, movement, and death. It is now clear that protein and lipid kinases as well as phosphatases are causally involved in human disease, especially in cancer. The first part of this review tries to compile our current knowledge about the involvement of protein kinases in human cancer. Phosphatases as well as phospholipid kinases will be omitted from this article for the purpose of simplification. In the second part an updated list of ongoing clinical trials involving protein kinases as targets for tumor therapy will be given, together with a brief summary of technical approaches in targeting protein kinases for therapy. Copyright 2001 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574762     DOI: 10.1159/000055106

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  5 in total

1.  Biomolecular interaction analysis in functional proteomics.

Authors:  D Moll; A Prinz; F Gesellchen; S Drewianka; B Zimmermann; F W Herberg
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 2.  Bacterial serine/threonine protein kinases in host-pathogen interactions.

Authors:  Marc J Canova; Virginie Molle
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 3.  Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.

Authors:  Kellie Burnside; Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2011-07       Impact factor: 3.165

4.  Role of network branching in eliciting differential short-term signaling responses in the hypersensitive epidermal growth factor receptor mutants implicated in lung cancer.

Authors:  Jeremy Purvis; Vibitha Ilango; Ravi Radhakrishnan
Journal:  Biotechnol Prog       Date:  2008-04-16

5.  Optimization of luminescent assay for screening of cyclin-dependent kinase 2 inhibitors.

Authors:  M P Suthar; M M Patel
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.